Sleep Apnea Devices Market Size, Share | Industry Report 2024

The global sleep apnea devices market was valued at $4.8bn in 2016 and is anticipated to reach $8.1bn by 2024.

The sleep apnea devices market is expected to grow with a lucrative CAGR of 7.9% over the forecast period, owing to factors such as growing aging population, increasing the prevalence of respiratory and sleep disorders, lifestyle factors such as smoking, substance abuse, and environmental pollution. Sleep apnea is a highly prevalent condition across different age groups however, most of the people are not aware of their condition. Due to this condition, the breathing pattern is distorted due to the lack of oxygen supply during sleep and is associated with snoring and restlessness due to increased airway resistance.

The population which is at an increased risk of suffering from sleep disorders include male candidates who are obese, suffer from hypertension, who use alcohol and sedatives regularly, are prone to smoking, have a family history of OSA and people who suffer from endocrine and metabolic disorders. The different types of sleep apnea include complex sleep apnea, obstructive sleep apnea (OSA), central sleep apnea (CSA). The OSA is the most commonly identified type of condition, which can be treated using sleep masks and positive airway pressure (PAP) devices.

In 2016, North America accounted for a dominant share of over 37.5% due to the high disease burden and growing awareness about sleep apnea and associated co-morbidities. The U.S. region contributes the bulk of the revenue due to higher patient volume, treatment rate and availability of reimbursement. Moreover, the presence of sleep diagnostic centers and collaboration, growing demand for dental sleep apnea appliances in the region are expected to positively reinforce growth over the forecast period.

By 2024, Asia-Pacific is expected to emerge as the fastest growing region with a CAGR of 8.7%. The high growth is anticipated because of rising prevalence of obesity, diabetes, and hypertension in the region. Moreover, increase in air pollution, growing consumption of tobacco and alcohol, and highly stressful lifestyle are expected to drive the prevalence of sleep disorders. For instance, countries such as India and China now have the highest number of obese and diabetic population. Moreover, rising awareness and introduction of several low-cost products to cater to the growing needs of the region are expected to reinforce demand over the forecast period.

Click the link below to view the report description:
www.ameriresearch.com/product/sleep-apnea-devices-market/

Key findings from the study: -
• The sleep apnea devices market is expected to grow with a lucrative CAGR of 7.9% over the forecast period, owing to factors such as growing aging population, increasing the prevalence of respiratory and sleep disorders, lifestyle factors such as smoking, substance abuse, and environmental pollution.
• The different types of sleep apnea include complex sleep apnea, obstructive sleep apnea (OSA), central sleep apnea (CSA).
• In 2015, the PAP devices accounted for over 43% the market share and are expected to extend their dominance over the forecast period.
• The key market participants include ResMed, Invacare Corporation, ImThera Medical Inc, Fisher & Paykel Healthcare, Phillips Respironics, Curative Medical Inc., BMC Medical Co.Ltd, GE Healthcare, Braebon Medical Corporation, Cadwell Laboratories and Becton, Dickinson and Company.

Ameri Research has segmented the Sleep Apnea Devices Market by product type, end-use and region:

Market Segmentation:

Sleep Apnea Devices Market by Product (Revenue, Million, 2014 – 2024)
• Diagnostic Devices
• Actigraphy Systems
• Polysomnography (PSG) Devices
• Respiratory Polygraph
• Single Channel Screening Devices (Pulse Oximeters)
• Therapeutic Devices
• Adaptive Servo Ventilation (ASV) Systems
• Airway Clearance System
• Positive Airway Pressure (PAP) Devices
• Oral Appliances
• Oxygen Devices

Sleep Apnea Devices Market Regional Outlook (Revenue, USD Million, 20124- 2024)
• North America
o U.S.
o Canada

• Europe
o UK
o Germany
o France
o Italy
o Spain

• Asia Pacific
o Japan
o China
o India
o Australia

• Latin America
o Brazil
o Mexico
o Columbia
• Middle East and Africa
o South Africa
o Saudi Arabia

Browse Full Report @ www.ameriresearch.com/product/sleep-apnea-devices-market/

About Us:

Ameri Research Inc. (www.ameriresearch.com) is a U.S. based market research and consulting company, registered in the State of Florida and headquartered in Tampa Bay Area. At Ameri Research we are passionately curious about people, markets, brands and society. Our ability to gauge market movements, deep expertise in data science, strong domain expertise and years of collective global experiences helps us to bring unmatched quality in deliverables to our clients. With carefully planned systems and processes in place, we cater to the requirements of our clients in a timely and cost-efficient manner, bringing increased predictability to their business. Each year we are publishing more than 100 syndicated reports in healthcare, chemicals, materials, food & beverages, defense & aerospace, media & entertainment, sports & fitness, and energy. We offer our clients a unique depth of knowledge and expertise around-

Market Mapping
Opportunity Assessment
Positioning
Pricing Analysis
Market Entry Strategy
Competitive Intelligence
Program Evaluation
Performance Reporting
Data Analytics
Developing a culture of collaboration and curiosity, we attract the highest caliber of likeminded people having ability to influence and shape the future.

Follow us on LinkedIn for our latest upcoming reports www.linkedin.com/company/ameri-research-inc./
Follow us on Facebook for our latest upcoming reports www.facebook.com/AmeriResearchInc/
Follow us on Twitter for our latest upcoming reports www.twitter.com/AmeriResearch

Contact Us:

Ameri Research Inc.
6816 Muncaster Ct,
Tampa, FL 33625
United States.
Tel: 1-813-666-0858
Email: Inquiry@ameriresearch.com
Web: www.ameriresearch.com

This release was published on openPR.